AWM
PACB icon

Axxcess Wealth Management’s Pacific Biosciences PACB Stock Holding History

Axxcess Wealth Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.6K Sell
24,178
-4,425
-15% -$6.43K ﹤0.01% 1046
2026
Q1 		$37.8K Hold
28,603
– – ﹤0.01% 373
2025
Q4 		$53.5K Sell
28,603
-257
-0.9% -$494 ﹤0.01% 1030
2025
Q3 		$36.9K Sell
28,860
-1,000
-3% -$1.35K ﹤0.01% 922
2025
Q2 		$37K Sell
29,860
-978
-3% -$1.13K ﹤0.01% 877
2025
Q1 		$36.4K Sell
30,838
-2,630
-8% -$4.03K ﹤0.01% 842
2024
Q4 		$61.2K Sell
33,468
-1,237
-4% -$2.42K ﹤0.01% 843
2024
Q3 		$59K Sell
34,705
-43
-0.1% -$71 ﹤0.01% 880
2024
Q2 		$47.6K Sell
34,748
-427
-1% -$862 ﹤0.01% 835
2024
Q1 		$132K Buy
35,175
+13,382
+61% +$78.4K ﹤0.01% 843
2023
Q4 		$214K Buy
21,793
+3,513
+19% +$28.7K 0.01% 763
2023
Q3 		$153K Buy
18,280
+3,494
+24% +$39.9K 0.01% 756
2023
Q2 		$197K Buy
14,786
+86
+0.6% +$1.04K 0.01% 557
2023
Q1 		$170K Buy
14,700
+3,221
+28% +$32K 0.01% 601
2022
Q4 		$93.9K Sell
11,479
-5,438
-32% -$46.9K 0.01% 595
2022
Q3 		$98K Sell
16,917
-1,066
-6% -$6.12K 0.01% 522
2022
Q2 		$79K Buy
17,983
+2,564
+17% +$15.6K 0.01% 522
2022
Q1 		$140K Sell
15,419
-2,326
-13% -$26.8K 0.01% 607
2021
Q4 		$363K Buy
+17,745
New +$428K 0.03% 430

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Axxcess Wealth Management's PACB Position: Q2 2026 in Review

Axxcess Wealth Management reduced its Pacific Biosciences (PACB) stake by 15% in Q2 2026, selling an estimated $6.43K and leaving 24,178 shares worth $40.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1046.

Axxcess Wealth Management first reported a position in PACB in Q4 2021 and has held it in 19 quarters since. The position peaked at $363K in Q4 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Axxcess Wealth Management held 24,178 shares of Pacific Biosciences worth $40.6K as of Q2 2026.
  • Axxcess Wealth Management sold 4,425 Pacific Biosciences shares in Q2 2026, an estimated $6.43K.
  • Pacific Biosciences made up ﹤0.01% of Axxcess Wealth Management's portfolio in Q2 2026, its #1046 holding.
  • Axxcess Wealth Management first reported a position in Pacific Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Axxcess Wealth Management's Pacific Biosciences position peaked at $363K in Q4 2021.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Axxcess Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.